Research byIrina Veith and colleagues created personalized organ-on-achipmodels of lung cancer with their autologous primary tumor,stromal, and immune cells isolated from tumor samplesand measured the response to anti-PD-1 treatment (Veith etal., 2024). The gene discussed is PDCD1; the disease is neoplasm.